Home / Sweden / Active Biotech AB
Active Biotech AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
78 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 5, 2014 | OrbiMed Advisors LLC | 1.40% | still open |
| September 25, 2014 | OrbiMed Advisors LLC | 1.30% | still open |
| September 24, 2014 | OrbiMed Advisors LLC | 1.22% | still open |
| September 23, 2014 | OrbiMed Advisors LLC | 1.22% | still open |
| September 17, 2014 | OrbiMed Advisors LLC | 1.01% | still open |
| September 16, 2014 | OrbiMed Advisors LLC | 1.01% | still open |
| September 12, 2014 | OrbiMed Advisors LLC | 0.90% | still open |
| September 11, 2014 | OrbiMed Advisors LLC | 0.90% | still open |
| September 10, 2014 | OrbiMed Advisors LLC | 0.80% | still open |
| September 9, 2014 | OrbiMed Advisors LLC | 0.80% | still open |
| September 5, 2014 | OrbiMed Advisors LLC | 0.75% | still open |
| September 4, 2014 | OrbiMed Advisors LLC | 0.75% | still open |
| September 2, 2014 | OrbiMed Advisors LLC | 0.63% | still open |
| September 1, 2014 | OrbiMed Advisors LLC | 0.63% | still open |
| July 21, 2014 | GSA Capital Partners LLP | 0.69% | still open |
| July 20, 2014 | GSA Capital Partners LLP | 0.69% | still open |
| July 2, 2014 | GSA Capital Partners LLP | 0.70% | still open |
| July 1, 2014 | GSA Capital Partners LLP | 0.70% | still open |
| May 5, 2014 | GSA Capital Partners LLP | 0.60% | still open |
| May 4, 2014 | GSA Capital Partners LLP | 0.60% | still open |
| March 25, 2014 | GSA Capital Partners LLP | 0.50% | still open |
| March 24, 2014 | GSA Capital Partners LLP | 0.50% | still open |
| January 30, 2013 | Oxford Asset Management | 0.59% | still open |
| January 29, 2013 | Oxford Asset Management | 0.59% | still open |
| December 14, 2012 | Oxford Asset Management | 0.69% | still open |
| December 13, 2012 | Oxford Asset Management | 0.69% | still open |
| November 2, 2012 | Oxford Asset Management | 0.79% | still open |
| November 1, 2012 | Oxford Asset Management | 0.79% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Active Biotech AB, source Finansinspektionen, data as at May 15, 2018, https://www.quivad.com/action/active-biotech-ab?page=2